Molecular Partners Offers USD 20m of American Depositary Shares

29 January 2025

•

CapLaw

Share on:

On 25 October 2024, Molecular Partners AG, a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics announced that it had priced an underwritten offering of 3,642,988 American Depositary Shares (ADSs) representing 3,642,988 new shares at an offering price of USD 5.49 per ADS amounting to gross proceeds of USD 20m. The offering included participation from a new investor HBM Healthcare Investments Ltd, which is a leading healthcare investor, as well as multiple existing investors.

CapLaw-2024-87

Back to the homepage

CapLaw Themes

CapLaw PDF Archive

Discover more articles

We provide up-to-date information on legal and regulatory developments regarding the capital markets, publish concise articles on developments in the Swiss and international financial markets, and announce recent deals and forthcoming events.

Editorial | Switzerland‘s IPO Market: Unlocking the Next Wave of Mid-Cap Listings

8 May 2026

By
Richard Schindler

The Swiss IPO market saw a welcome reopening in 2024 and 2025. Galderma, Sunrise, SMG Swiss Marketplace Group and Bioversys demonstrated that SIX Swiss Exchange is a competitive listing venue across deal sizes and sectors. From the perspective of a domestically anchored capital markets bank, this is the right starting point: the infrastructure works, the…

Read more: Editorial | Switzerland‘s IPO Market: Unlocking the Next Wave of Mid-Cap Listings

Securities

CapLaw-2026-17
Back from Moratorium: Bondholder-Driven Restructuring and Going Public

8 May 2026

By
Matthias Courvoisier
/
Kiara Sharifi

This article analyzes the key legal issues in HT5‘s restructuring and return to the public markets. It reviews the hybrid bond reorganization (out-of-moratorium vs. in-moratorium reorganization) and related takeover and reporting questions, as well as the evidentiary approach applied to lifting the moratorium. It further addresses how the shares required for the conversion were made…

Read more: Back from Moratorium: Bondholder-Driven Restructuring and Going Public

Securities

CapLaw-2026-18
The Impact of the New Swiss ForeignDirect Investment (FDI) Regime onCapital Market Transactions

8 May 2026

By
Thomas U. Reutter
/
Sandro Fehlmann

The Swiss Parliament has approved the Investment Screening Act (ISA) which forms the basis of the Swiss FDI regime, on 19 December 2025. As no popular referendum had been initiated by the end of the respective deadline on 17 April 2026, the ISA will enter into force and the Federal Government is expected to publish…

Read more: The Impact of the New Swiss ForeignDirect Investment (FDI) Regime onCapital Market Transactions

Regulatory

CapLaw-2026-19
The New Payment Instrument InstitutionsLicense under the revised Swiss Financial Institutions Act – An Opportunity forForeign Payment Service Providers?

8 May 2026

By
Alexander Wherlock

On 22 October 2025, the Swiss Federal Council initiated the consultation process for a revision of the Financial Institutions Act. The proposed legislation aims to increase financial innovation under the Swiss regulatory framework. Under the revised Financial Institutions Act, the Federal Council, intends to introduce a new license category, the “Payment Instrument Institution“ which will…

Read more: The New Payment Instrument InstitutionsLicense under the revised Swiss Financial Institutions Act – An Opportunity forForeign Payment Service Providers?

Regulatory

CapLaw-2026-20
HT5 AG‘s Merger with Centiel SA and Placement of 15,386,988 Shares

8 May 2026

By
CapLaw

On 13 April 2026, the shareholders of HT5 AG, a company with shares listed on SIX Swiss Exchange, and Centiel SA approved their merger, creating a listed Swiss technology company active in the uninterruptible power supply (UPS) sector. Trading in the shares of the merged company under the name Centiel AG and the ticker CNTL…

Read more: HT5 AG‘s Merger with Centiel SA and Placement of 15,386,988 Shares

News, Deals & Cases

CapLaw-2026-21
Mondelēz International‘s Issuance of CHF 850 Million Bonds

8 May 2026

By
CapLaw

On 10 April 2026, Mondelēz International, Inc., placed bonds in the aggregate amount of CHF 850 million in Switzerland. The offering included CHF 325 million aggregate principal amount of 0.9575% senior notes due 2029, CHF 245 million aggregate principal amount of 1.2713% senior notes due 2032 and CHF 280 million aggregate principal amount of 1.6250% senior notes due 2036. Deutsche…

Read more: Mondelēz International‘s Issuance of CHF 850 Million Bonds

News, Deals & Cases

CapLaw-2026-22

Molecular Partners Offers USD 20m of American Depositary Shares

CapLaw Themes

CapLaw PDF Archive

Discover more articles

Editorial | Switzerland‘s IPO Market: Unlocking the Next Wave of Mid-Cap Listings

Back from Moratorium: Bondholder-Driven Restructuring and Going Public

The Impact of the New Swiss ForeignDirect Investment (FDI) Regime onCapital Market Transactions

The New Payment Instrument InstitutionsLicense under the revised Swiss Financial Institutions Act – An Opportunity forForeign Payment Service Providers?

HT5 AG‘s Merger with Centiel SA and Placement of 15,386,988 Shares

Mondelēz International‘s Issuance of CHF 850 Million Bonds